tranexamic acid has been researched along with Carcinoma, Transitional Cell in 2 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Carcinoma, Transitional Cell: A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maresca, G | 1 |
| Royle, J | 1 |
| Donaldson, JF | 1 |
| Nagai, N | 1 |
2 other studies available for tranexamic acid and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Tranexamic acid-induced ureteric clot obstruction in a patient with urothelial cell carcinoma resulting in upper urinary tract perforation.
Topics: Aged; Carcinoma, Transitional Cell; Female; Humans; Kidney Neoplasms; Thrombosis; Tranexamic Acid; U | 2022 |
[Coagulation and fibrinolysis system in bladder tumor. 2. Effect of fibrinolytic and anti-fibrinolytic agents on BBN-induced rat bladder tumor].
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinoma, Transitional Cell; Cyclohexanecarboxylic Acids; Ma | 1985 |